v3.26.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 305,427 $ 37 $ 429,657 $ (522) $ (123,745)
Beginning balance, shares at Dec. 31, 2024   36,580,202      
Stock-based compensation expense 4,040   4,040    
Issuance of common stock upon exercise of stock options 6   6    
Issuance of common stock upon exercise of stock options, shares   3,240      
Repurchase of unvested restricted common stock (1)   (1)    
Repurchase of unvested restricted common stock, shares   (86,008)      
Net loss (24,063)       (24,063)
Change in unrealized gain (loss) on investments, net of tax 427     427  
Ending balance at Mar. 31, 2025 285,836 $ 37 433,702 (95) (147,808)
Ending balance, shares at Mar. 31, 2025   36,497,434      
Beginning balance at Dec. 31, 2024 305,427 $ 37 429,657 (522) (123,745)
Beginning balance, shares at Dec. 31, 2024   36,580,202      
Net loss (77,720)        
Change in unrealized gain (loss) on investments, net of tax 667        
Ending balance at Sep. 30, 2025 511,617 $ 48 712,889 145 (201,465)
Ending balance, shares at Sep. 30, 2025   47,650,216      
Beginning balance at Mar. 31, 2025 285,836 $ 37 433,702 (95) (147,808)
Beginning balance, shares at Mar. 31, 2025   36,497,434      
Stock-based compensation expense 4,389   4,389    
Issuance of common stock upon exercise of stock options, shares   243      
Net loss (26,732)       (26,732)
Change in unrealized gain (loss) on investments, net of tax 19     19  
Ending balance at Jun. 30, 2025 263,512 $ 37 438,091 (76) (174,540)
Ending balance, shares at Jun. 30, 2025   36,497,677      
Stock-based compensation expense 4,735   4,735    
Issuance of common stock upon exercise of stock options 635   635    
Issuance of common stock upon exercise of stock options, shares   94,847      
Issuance of common stock from underwritten public offering, net of issuance costs, shares   11,057,692      
Issuance of common stock from underwritten public offering, net of issuance costs 269,439 $ 11 269,428    
Net loss (26,925)       (26,925)
Change in unrealized gain (loss) on investments, net of tax 221     221  
Ending balance at Sep. 30, 2025 511,617 $ 48 712,889 145 (201,465)
Ending balance, shares at Sep. 30, 2025   47,650,216      
Beginning balance at Dec. 31, 2025 $ 484,653 $ 48 719,287 546 (235,228)
Beginning balance, shares at Dec. 31, 2025 47,772,567 47,772,567      
Stock-based compensation expense $ 6,963   6,963    
Issuance of common stock upon exercise of stock options 809   809    
Issuance of common stock upon exercise of stock options, shares   80,867      
Vesting of restricted stock units, shares   6,994      
Repurchase of unvested restricted common stock (5)   (5)    
Repurchase of unvested restricted common stock, shares   (52,975)      
Net loss (19,857)       (19,857)
Change in unrealized gain (loss) on investments, net of tax (1,051)     (1,051)  
Ending balance at Mar. 31, 2026 471,512 $ 48 727,054 (505) (255,085)
Ending balance, shares at Mar. 31, 2026   47,807,453      
Beginning balance at Dec. 31, 2025 $ 484,653 $ 48 719,287 546 (235,228)
Beginning balance, shares at Dec. 31, 2025 47,772,567 47,772,567      
Issuance of common stock upon exercise of stock options, shares 361,827        
Net loss $ (116,707)        
Change in unrealized gain (loss) on investments, net of tax (2,661)        
Ending balance at Sep. 30, 2026 $ 391,190 $ 48 745,192 (2,115) (351,935)
Ending balance, shares at Sep. 30, 2026 48,088,413 48,088,413      
Beginning balance at Mar. 31, 2026 $ 471,512 $ 48 727,054 (505) (255,085)
Beginning balance, shares at Mar. 31, 2026   47,807,453      
Stock-based compensation expense 7,202   7,202    
Issuance of common stock upon exercise of stock options 1,592   1,592    
Issuance of common stock upon exercise of stock options, shares   147,626      
Net loss (56,615)       (56,615)
Change in unrealized gain (loss) on investments, net of tax (765)     (765)  
Ending balance at Jun. 30, 2026 422,926 $ 48 735,848 (1,270) (311,700)
Ending balance, shares at Jun. 30, 2026   47,955,079      
Stock-based compensation expense 7,634   7,634    
Issuance of common stock upon exercise of stock options 1,710   1,710    
Issuance of common stock upon exercise of stock options, shares   133,334      
Net loss (40,235)       (40,235)
Change in unrealized gain (loss) on investments, net of tax (845)     (845)  
Ending balance at Sep. 30, 2026 $ 391,190 $ 48 $ 745,192 $ (2,115) $ (351,935)
Ending balance, shares at Sep. 30, 2026 48,088,413 48,088,413